Claire Mazumdar
Director, Chief Executive Officer · 5 filings · Latest: Apr 16, 2026
Bicara Therapeutics Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Mar 4, 2026 | Sale | $18.73 | 2,631 | $49.3K | 339,392 | |
BCAX | Claire Mazumdar | Director, Chief Executive Officer | Mar 4, 2026 | Option Exercise | $3.79 | 2,631 | $10.0K | 342,023 | |
BCAX | Mazumdar Claire | — | Mar 6, 2026 | Proposed Sale | $19.80 | 3,817 | $75.6K | — | |
BCAX | Mazumdar Claire | — | Mar 5, 2026 | Proposed Sale | $18.74 | 1,786 | $33.5K | — | |
BCAX | Mazumdar Claire | — | Mar 4, 2026 | Proposed Sale | $18.73 | 2,631 | $49.3K | — | |
BCAX | Mazumdar Claire | — | Nov 24, 2025 | Proposed Sale | $18.86 | 41,163 | $776.4K | — | |
BCAX | Mazumdar Claire | — | Oct 16, 2025 | Proposed Sale | $18.83 | 24,103 | $453.8K | — | |
BCAX | Mazumdar Claire | — | Oct 15, 2025 | Proposed Sale | $18.84 | 13,289 | $250.4K | — | |
BCAX | Mazumdar Claire | — | Oct 13, 2025 | Proposed Sale | $18.92 | 11,445 | $216.5K | — |
← Previous
Page 2 of 2